We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Turning Stem Cells from Fat into Blood Vessels

By LabMedica International staff writers
Posted on 13 Aug 2012
Autologous adult stem cells extracted via liposuction from fat tissue can provide the raw materials for growing tissue-engineered blood vessel (TEBV) in the lab, according to a new study.

Researchers at the University of Oklahoma (Norman, USA) first differentiated adipose-derived stem cells into smooth muscle cells (SMCs), and then seeded them onto a flat sheet of the human amniotic membrane--a very thin collagen membrane--used as a biological substrate to fabricate the small-diameter TEBVs. More...
To develop a tubular construct similar to that of a muscular artery's tunica media layer, the cell-seeded sheet was wrapped around a 3-mm removable mandrel with six to seven revolutions. After a two-week static culture period, the fabricated TEBV was assessed for biochemical and mechanical properties.

The researchers examined and compared the contraction of the vessel in response to carbachol--a specific agonist for SMCs--to that of porcine coronary arteries; burst pressure and elastic modulus tests were also conducted. The researchers found that the thickness and architecture of the engineered vessel matched that of a porcine coronary artery in a histological analysis; it also performed better than the porcine vessel for elasticity in a tensile strength test. However, the burst pressure was too low, at about 150 mm Hg, while native tissue withstands 1,000 mm Hg. The problem, according to the researchers, appeared to be that the layers of the rolled-up vessel are not adhering well to one another.

The researchers found that the mechanical integrity of the construct could be further improved by exposure to appropriate physiological conditions in a perfusion bioreactor, and that adipose-derived endothelial cells also could be seeded into the lumen of the construct to prevent platelet adhesion. The study was presented at the American Heart Association Basic Cardiovascular Sciences 2012 scientific sessions, held during July 2012 in New Orleans (LA, USA).

“These liposuction-derived vessels, grown in a lab, could help solve major problems associated with grafting blood vessels from elsewhere in the body or from using artificial blood vessels that are not living tissue,” concluded lead author and study presenter Matthias Nollert, PhD, and colleagues of the school of chemical, biological, and materials engineering. “Our engineered blood vessels have good mechanical properties and we believe they will contract normally when exposed to hormones.”

Related Links:

University of Oklahoma




New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.